Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Intergroup Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection, Followed by 5-FU/Leucovorin for Patients With Colon Cancer

NCT00002525 is registered in ClinicalTrials.gov with ECOG-ACRIN Cancer Research Group as lead sponsor.

NCT NCT00002525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Intergroup Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection, Followed by 5-FU/Leucovorin for Patients With Colon Cancer
Lead sponsor
ECOG-ACRIN Cancer Research Group
Phase
Phase 3
Overall status
Terminated
Start date
October 1, 1993
Completion date
April 30, 2015
Enrollment
859 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer